🇺🇸 FDA
Patent

US 6787365

Inhibition of L-selectin and P-selectin mediated binding using heparin

expired A61KA61K31/727

Quick answer

US patent 6787365 (Inhibition of L-selectin and P-selectin mediated binding using heparin) held by The Regents of the University of California expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/727